Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Microbial Immunity and Vaccines

Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA

Abiodun David Ogunniyi, Matthew C. Woodrow, Jan T. Poolman, James C. Paton
Abiodun David Ogunniyi
Department of Molecular Biosciences, Adelaide University, Adelaide, South Australia 5005, Australia, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew C. Woodrow
Department of Molecular Biosciences, Adelaide University, Adelaide, South Australia 5005, Australia, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan T. Poolman
GlaxoSmithKline Biologicals, Rue de l'Institut 89, B-1330 Rixensart, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James C. Paton
Department of Molecular Biosciences, Adelaide University, Adelaide, South Australia 5005, Australia, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.10.5997-6003.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Purification of His6-tagged truncated CbpA fragment from recombinant E. coli. (A) SDS-PAGE analysis (12% gel) of protein samples from various stages of the purification procedure. Lanes: 1, lysate of recombinant E. coliexpression construct before induction; 2, 100,000 ×g supernatant of E. coli lysate after a 4-h induction with IPTG before being loaded onto Ni-NTA resin; 3, unbound fraction washed from the resin; 4, purified His6-tagged CbpA fragment (approximate mass, 75 kDa) after elution from Ni-NTA with imidazole. (B) Western immunoblot analysis of corresponding samples in panel A after they were electroblotted onto nitrocellulose. The samples were reacted with anti-His6monoclonal antibody.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Western immunoblot analysis of purified PdB (53 kDa) and His6-tagged CbpA fragment (75 kDa) (A) and of whole-cell lysates of S. pneumoniae D39 (B), isogenic CbpA-negative D39 (4) (C), and isogenic PspA-negative D39 (4) (D) showing specificity of antibody responses to the protein antigens. The proteins were separated by SDS-PAGE and then electroblotted onto nitrocellulose. They were then reacted with sera from the groups of mice immunized with the proteins in different adjuvant combinations. Lane C, Coomassie blue-stained gel showing the relative mobilities of the two purified proteins. Lanes 1 to 8, nitrocellulose membrane strips reacted with sera from mice immunized with AlPO4 adjuvant (lane 1), MPL plus AlPO4(lane 2), PdB in AlPO4 adjuvant (lane 3), PdB in MPL plus AlPO4 (lane 4), CbpA in AlPO4 adjuvant (lane 5), CbpA in MPL plus AlPO4 (lane 6), a combination of PdB and CbpA in AlPO4 adjuvant (lane 7), and a combination of PdB and CbpA in MPL plus AlPO4 (lane 8). The arrows show a band of approximately 60 kDa cross-reacting with the anti-CbpA serum pool.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Survival times for mice after intraperitoneal challenge. Groups of 13 or 14 BALB/c mice were immunized with the indicated antigens and challenged 2 weeks after the third immunization with approximately 1.3 × 105 CFU of the capsular type 2 strain D39. The broken lines denote the median survival time for each group.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Survival times for mice after intraperitoneal challenge. Groups of 14 or 15 BALB/c mice were immunized with the indicated antigens and challenged 2 weeks after the third immunization with approximately 1.3 × 107 CFU of capsular type 2 strain D39. The broken lines denote the median survival time for each group.

Tables

  • Figures
  • Table 1.

    Antibody titers obtained from mice immunized with PdB and CbpA

    Immunization groupAntibody titer (ELISA)a against:
    PdBCbpA
    Placebo (AlPO4 or MPL + AlPO4)−b−
    PdB-AlPO411,000−
    PdB-MPL-AlPO440,000−
    CbpA-AlPO4−74,000
    CbpA-MPL-AlPO4−140,000
    PdB-CbpA-AlPO424,00067,200
    PdB-CbpA-MPL-AlPO439,000135,000
    • ↵a ELISA titers were defined as the reciprocal of the dilution of serum yielding 50% of the maximumA405 above the background.

    • ↵b −, <100.

  • Table 2.

    Statistical comparison of median survival timesa

    Immunization group Statistical difference (P value) between indicated groups
    AlPO4MPL + AlPO4PdB + AlPO4PdB + MPL + AlPO4CbpA + AlPO4CbpA + MPL + AlPO4PdB + CbpA + AlPO4PdB + CbpA + MPL + AlPO4
    AlPO4<0.025≪0.001ND≪0.001ND≪0.001ND
    MPL + AlPO4<0.001ND≪0.001ND≪0.001ND≪0.001
    PdB + AlPO4NSND≪0.01 ≪0.001ND≪0.001ND
    PdB + MPL + AlPO4ND≪0.001<0.025NDNSNDNS
    CbpA + AlPO4NSNDNSNDNSNSND
    CbpA + MPL + AlPO4ND<0.001ND<0.05 NSNDNS
    PdB + CbpA + AlPO4<0.025ND<0.01 NDNSNDNS
    PdB + CbpA + MPL + AlPO4ND≪0.001NDNSNDNSNS
    • ↵a Differences in median survival times between groups of mice immunized with the indicated antigen formulations were analyzed using the Mann-Whitney U test (one tailed). P values are indicated for groups challenged with 1.3 × 105 CFU or 1.3 × 107 CFU (in bold) of capsular type 2 strain D39. ND, not determined; NS, not significant.

PreviousNext
Back to top
Download PDF
Citation Tools
Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA
Abiodun David Ogunniyi, Matthew C. Woodrow, Jan T. Poolman, James C. Paton
Infection and Immunity Oct 2001, 69 (10) 5997-6003; DOI: 10.1128/IAI.69.10.5997-6003.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA
Abiodun David Ogunniyi, Matthew C. Woodrow, Jan T. Poolman, James C. Paton
Infection and Immunity Oct 2001, 69 (10) 5997-6003; DOI: 10.1128/IAI.69.10.5997-6003.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antigens, Bacterial
Bacterial Proteins
Pneumococcal Infections
Streptolysins
Vaccines, Synthetic

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522